400
Views
0
CrossRef citations to date
0
Altmetric
Extra View

Generation of a novel murine model of Aβ deposition based on the expression of human wild-type amyloid precursor protein gene

&
Pages 346-349 | Published online: 09 Aug 2012

References

  • Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century. Sci Transl Med 2011; 3:77sr1
  • Cole SL, Vassar R. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 2008; 283:29621 - 5; http://dx.doi.org/10.1074/jbc.R800015200; PMID: 18650431
  • Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer’s disease. Mol Brain 2011; 4:3; http://dx.doi.org/10.1186/1756-6606-4-3; PMID: 21214928
  • Wolfe MS. The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry 2006; 45:7931 - 9; http://dx.doi.org/10.1021/bi060799c; PMID: 16800619
  • Hall AM, Roberson ED. Mouse models of Alzheimer's disease. [Epub ahead of print] Brain Res Bull 2011; 28; PMID: 22142973
  • Crews L, Rockenstein E, Masliah E. APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct Funct 2010; 214:111 - 26; http://dx.doi.org/10.1007/s00429-009-0232-6; PMID: 20091183
  • Götz J, Ittner LM. Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci 2008; 9:532 - 44; http://dx.doi.org/10.1038/nrn2420; PMID: 18568014
  • Kokjohn TA, Roher AE. Amyloid precursor protein transgenic mouse models and Alzheimer’s disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement 2009; 5:340 - 7; http://dx.doi.org/10.1016/j.jalz.2009.03.002; PMID: 19560104
  • Ashe KH, Zahs KR. Probing the biology of Alzheimer’s disease in mice. Neuron 2010; 66:631 - 45; http://dx.doi.org/10.1016/j.neuron.2010.04.031; PMID: 20547123
  • Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004; 7:954 - 60; http://dx.doi.org/10.1038/nn1302; PMID: 15311281
  • Higgins LS, Catalano R, Quon D, Cordell B. Transgenic mice expressing human β-APP751, but not mice expressing β-APP695, display early Alzheimer’s disease-like histopathology. Ann N Y Acad Sci 1993; 695:224 - 7; http://dx.doi.org/10.1111/j.1749-6632.1993.tb23056.x; PMID: 8239286
  • Vidal R, Sammeta N, Garringer HJ, Sambamurti K, Miravalle L, Lamb BT, et al. The Psen1-L166P-knock-in mutation leads to amyloid deposition in human wild-type amyloid precursor protein YAC transgenic mice. [Epub ahead of print] FASEB J 2012; 29; PMID: 21908716
  • Murrell J, Evans RM, Boyer PJ, Piccardo P, Towfighi J, Ghetti B. Alzheimer disease with onset in adolescence due to a novel mutation in Presenilin 1 (L166P).. [Abstract 187] J Neuropathol Exp Neurol 2000; 59
  • Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A 2002; 99:8025 - 30; http://dx.doi.org/10.1073/pnas.112686799; PMID: 12048239
  • Bentahir M, Nyabi O, Verhamme J, Tolia A, Horré K, Wiltfang J, et al. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 2006; 96:732 - 42; http://dx.doi.org/10.1111/j.1471-4159.2005.03578.x; PMID: 16405513
  • Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 2006; 7:940 - 6; http://dx.doi.org/10.1038/sj.embor.7400784; PMID: 16906128
  • Jankowsky JL, Younkin LH, Gonzales V, Fadale DJ, Slunt HH, Lester HA, et al. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem 2007; 282:22707 - 20; http://dx.doi.org/10.1074/jbc.M611050200; PMID: 17556372
  • Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet 1993; 5:22 - 30; http://dx.doi.org/10.1038/ng0993-22; PMID: 8220418
  • Wang R, Wang B, He W, Zheng H. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J Biol Chem 2006; 281:15330 - 6; http://dx.doi.org/10.1074/jbc.M512574200; PMID: 16574645
  • Flood DG, Reaume AG, Dorfman KS, Lin YG, Lang DM, Trusko SP, et al. FAD mutant PS-1 gene-targeted mice: increased A β 42 and A β deposition without APP overproduction. Neurobiol Aging 2002; 23:335 - 48; http://dx.doi.org/10.1016/S0197-4580(01)00330-X; PMID: 11959395
  • Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry 2005; 44:10810 - 21; http://dx.doi.org/10.1021/bi0508237; PMID: 16086583
  • Wang R, Wang B, He W, Zheng H. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J Biol Chem 2006; 281:15330 - 6; http://dx.doi.org/10.1074/jbc.M512574200; PMID: 16574645
  • Sambamurti K, Greig NH, Utsuki T, Barnwell EL, Sharma E, Mazell C, et al. Targets for AD treatment: conflicting messages from γ-secretase inhibitors. J Neurochem 2011; 117:359 - 74; http://dx.doi.org/10.1111/j.1471-4159.2011.07213.x; PMID: 21320126